Ameriprise’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Ameriprise’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-37,448	Closed	-$1.35M	–	3937
2020 Q4	$1.35M	Sell	37,448 -1,387	-4%	-$48.6K	﹤0.01%	2954
2020 Q3	$1.09M	Sell	38,835 -4,874	-11%	-$172K	﹤0.01%	2931
2020 Q2	$1.89M	Sell	43,709 -8,020	-16%	-$363K	﹤0.01%	2633
2020 Q1	$1.97M	Buy	51,729 +4,893	+10%	+$191K	﹤0.01%	2487
2019 Q4	$1.27M	Buy	+46,836	New	+$1.18M	﹤0.01%	2957

Ameriprise's VIE Position: Q1 2021 in Review

Ameriprise sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 37,448 shares — an estimated $1.35M sold.

Ameriprise first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $1.97M in Q1 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Ameriprise reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Ameriprise sold 37,448 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $1.35M.
Ameriprise first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Ameriprise's Viela Bio, Inc. Common Stock position peaked at $1.97M in Q1 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.